CAROLYN YI: Open Payments
NPI 1710655857 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,273 in 144 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,999 · 2025 $3,273
Food & beverage: $3,159Education: $113
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $417 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $340 |
| PFIZER INC. | 13 | $327 |
| UCB, Inc. | 14 | $297 |
| GENZYME CORPORATION | 9 | $289 |
| Amgen Inc. | 11 | $221 |
| Galderma Laboratories, L.P. | 11 | $217 |
| Lilly USA, LLC | 10 | $187 |
| Janssen Biotech, Inc. | 8 | $177 |
| Botanix SB Inc | 2 | $157 |
Products named: DUPIXENT, CIBINQO, Winlevi, Bimzelx, SKYRIZI, Otezla, TREMFYA, RINVOQ.
Industry payments across DC — which companies pay providers there.
